Back to News
Market Impact: 0.35

Meta: This Stock Is Heating Up Again As Capex Cycle Nears Its Peak

Corporate EarningsCompany FundamentalsCapital Returns (Dividends / Buybacks)Analyst Insights
Meta: This Stock Is Heating Up Again As Capex Cycle Nears Its Peak

Meta is reiterated as a “Buy,” with analysts expecting capex to peak in 2026 and normalize in 2027. Core ads remain strong: impressions grew 19% y/y and average revenue per daily active person rose 27% y/y, supporting a 41% operating margin. Despite heavy spending, Q1 free cash flow was $12.4B, reinforcing long-term value as profitability holds.

Analysis

The key upside mechanism is not this year’s ad strength; it is the market’s tendency to re-rate spend-heavy platforms once the capital intensity curve visibly rolls over. If capex really peaks in 2026, the stock should start discounting a 2027 free-cash-flow inflection well before the dollars actually decline, creating room for multiple expansion even if growth moderates. That is the second-order winner: META’s own equity, but also the infrastructure vendors feeding the buildout, which can stay bid into 2026 while the market anticipates the spending plateau.

Competitive pressure is asymmetric. A stronger META ad engine tends to pull incremental budget from lower-ROI channels first, which is bad for smaller ad platforms and weaker performance-ad intermediaries before it hurts the large-scale duopoly. The risk is that investors confuse “peak capex” with a clean earnings tailwind; if spend persists because AI returns lag, margins can stay pinned and the market will reprice META as a utility-like spender rather than a cash compounder. The real tell over the next 1-3 quarters is not narrative, but whether operating margin holds above high-30s while cash generation remains resilient.

Contrarian view: consensus may be underestimating how quickly valuation can expand once capex normalizes, because the stock usually rerates on visibility, not on realized savings. Conversely, if capex is pushed out beyond 2026 or incremental ad monetization stalls, the thesis is deferred rather than disproven. Falsifiers: a renewed upward capex revision, operating margin slipping below ~38%, or free cash flow failing to inflect despite continued spend discipline.

More News